Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study just published in the journal Obesity Science and Practice. Using national… read more
Author Archives: cmccormick
FDA Issues Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products and Publishes Updated Structured Product Labeling (SPL)
On December 14, 2023, the U.S. Food and Drug Administration provided an update related to serious adverse event reporting mandated by the Modernization… read more
Dr. Daniele Wikoff has been appointed as new Chief Scientific Officer
Case Study of In Silico Approach to Assessing Carcinogenicity
Two toxicologists from ToxStrategies’ Pharmaceuticals Practice are among the team with a new publication concerning the use of in silico (computer modeling) approaches… read more
Congressional Briefings on CBD Regulatory Status
New Publication Assessing Worker Exposure to 1,3-butadiene During Chemical Manufacturing
ToxStrategies’ Scientists Publish Acute/Short-term Inhalation Guideline for Manganese Supported by PBPK Modeling
ToxStrategies is Presenting at SETAC 2023
ToxStrategies’ scientists will be participating in The Society of Environmental Toxicology and Chemistry’s (SETAC) 44th Annual Meeting this year, November 12–16, in Louisville,… read more